Covariate | Adjusted hazard ratio 4 | 95% CI | P -value |
---|---|---|---|
Biologics use | 0.63 | 0.49, 0.80 | <0.001 |
Male gender | 1.10 | 0.88, 1.38 | 0.39 |
Age at start, per year | 1.04 | 1.03, 1.05 | 0.000 |
Disease duration1, per year | 0.96 | 0.94, 0.99 | 0.02 |
Number of hospital visits, per year during observation | 1.01 | 1.01, 1.02 | 0.000 |
Methotrexate2 | 1.04 | 0.86, 1.26 | 0.68 |
Salfulsalazine2 | 1.01 | 0.84, 1.20 | 0.93 |
Hydroxychloroquine2 | 1.13 | 0.94, 1.36 | 0.19 |
Corticosteroids2 | 1.03 | 0.84, 1.28 | 0.75 |
Diabetes mellitus | 1.26 | 0.92, 1.74 | 0.15 |
Ischemic heart disease | 0.70 | 0.54, 0.92 | 0.01 |
Cerebrovascular disease | 0.75 | 0.45, 1.26 | 0.28 |
Hypertension | 1.21 | 0.98, 1.50 | 0.07 |
Chronic liver disease | 1.16 | 0.94, 1.42 | 0.17 |
Statins3 | 0.64 | 0.48, 0.86 | 0.003 |
Metformin3 | 0.67 | 0.45, 1.00 | 0.05 |
NSAIDs3 | 0.94 | 0.54, 1.64 | 0.83 |
Beta-blocker3 | 0.77 | 0.63, 0.93 | 0.008 |